Björn Papke und Andrew - Info zur Person

(1 - 16 von 19

)

Potential treatment strategy uncovered for pancreatic cancer - UNC...

unclineberger.org

... Venugopal Gunda, Mariaelena Pierobon, Andrew M. Waters, Samuel D. George, Garima Tomar, Bjoern Papke, G. Aaron Hobbs, Liang Yan, ...

Atypical KRASG12R mutant is impaired in PI3K signaling and...

www.bric.ku.dk

von A Rahbek-Damm · — ... {Andrew M.} and Diehl, {J. Nathaniel} and Bjoern Papke and Hodge, {Richard G.} and Klomp, {Jennifer E.} and Goodwin, {Craig M.} and DeLiberty, ...

Wood, Kris Cameron | Duke Cancer Institutewww.dukecancerinstitute.org › member › wood-kris

www.dukecancerinstitute.org

Citation Format: Craig M. Goodwin, Sehrish Javaid, Andrew M. Waters, Bjoern Papke, Runying Yang, Mariaelena Pierobon, Daniel M. Freed, ...

Targeting p130Cas- and microtubule-dependent MYC regulation ...journals.scholarsportal.info › nfp_tpammrpctemi

journals.scholarsportal.info

Andrew M. Waters · Tala O. Khatib · Bjoern Papke · Craig M. Goodwin · G. Aaron Hobbs · J. Nathaniel Diehl · Runying Yang · A. Cole Edwards ...

Low-Dose Vertical Inhibition of the RAF-MEK-ERK ...Elsevier

mayoclinic.elsevierpure.com

George, Antje Schaefer, Bjoern Papke, Kathleen Klotz-Noack, Andrew M. Waters, Craig M. Goodwin, Prson Gautam, Mariaelena Pierobon, Sen Peng, Thomas S.K George, Antje Schaefer, Bjoern Papke, Kathleen Klotz-Noack, Andrew M. Waters, Craig M. Goodwin, Prson Gautam, Mariaelena Pierobon, Sen Peng, Thomas S.K. ...

Low-Dose Vertical Inhibition of the RAF-MEK-ERK ...University of Helsinki

researchportal.helsinki.fi

George, Antje Schaefer, Bjoern Papke, Kathleen Klotz-Noack, Andrew M. Waters, Craig M. Goodwin, Prson Gautam, Mariaelena Pierobon, Sen Peng, Thomas S. K George, Antje Schaefer, Bjoern Papke, Kathleen Klotz-Noack, Andrew M. Waters, Craig M. Goodwin, Prson Gautam, Mariaelena Pierobon, Sen Peng, Thomas S. K. ...

Author Page for Yingyao Zhou - SSRN Papersprivpapers.ssrn.com › sol3 › cf_dev › AbsByAuth

privpapers.ssrn.com

Andrew M. Waters, Tala O. Khatib, Bjoern Papke, Craig Goodwin, G. Aaron Hobbs, J. Nathaniel Diehl, Katherine H. Walsh, Rita Sulahian, James McFarland, ...

Combination of ERK and autophagy inhibition as a treatment approach...

mdanderson.elsevierpure.com

von KL Bryant · · Zitiert von: 323 — ... Andrey P. Tikunov, Venugopal Gunda, Mariaelena Pierobon, Andrew M. Waters, Samuel D. George, Garima Tomar, Björn Papke, G. Aaron Hobbs, ... › ...

CHK1 protects oncogenic KRAS-expressing cells from DNA damage ...www.ncbi.nlm.nih.gov › articles › PMC

www.ncbi.nlm.nih.gov

Jennifer E. Klomp,1 Ye S. Lee,2 Craig M. Goodwin,1 Björn Papke,1 Jeff A. Klomp,1 Andrew M. Waters,1 Clint A. Stalnecker,1 Jonathan M. DeLiberty,2 Kristina ...

CHK1 protects oncogenic KRAS-expressing cells from DNA damage ...pubmed.ncbi.nlm.nih.gov › ...

pubmed.ncbi.nlm.nih.gov

von JE Klomp · · Zitiert von: 4 — Jennifer E Klomp , Ye S Lee , Craig M Goodwin , Björn Papke , Jeff A Klomp , Andrew M Waters , Clint A Stalnecker , Jonathan M DeLiberty ...

Altmetric – Combination of ERK and autophagy inhibition as a...

www.altmetric.com

... Andrey P. Tikunov, Venugopal Gunda, Mariaelena Pierobon, Andrew M. Waters, Samuel D. George, Garima Tomar, Björn Papke, G. Aaron Hobbs, Liang Yan, ...

Combination of ERK and autophagy inhibition as a treatment approach...

mayoclinic.pure.elsevier.com

... Sen Peng, Andrey P. Tikunov, Venugopal Gunda, Mariaelena Pierobon, Andrew M. Waters, Samuel D. George, Garima Tomar, Björn Papke, ...

Dr. Andrew Aguirre, MD – Boston, MA | Oncology

www.doximity.com

Adele Waters, Tala O. Khatib, Bjoern Papke, Craig M. Goodwin, G. Aaron Hobbs, J. Nathaniel Diehl, Runying Yang, A. Cole Edwards, Katherine H. Walsh, ...